Inflammation as a New Therapeutic Target among Older Patients with Ischemic Heart Disease
Journal of Clinical Medicine · 09.01.2024 · 13 (2) · 363
DOI: 10.3390/jcm13020363 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 09.01.2024. Verfasst von Daniela Maidana und 10 weiteren Autor:innen. Beteiligte Einrichtung: INCLIVA-Instituto de Investigación Sanitaria, Biomedical Research Institute, 46010 Valencia, Spain. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiovascular (CV) diseases remain a global health challenge, with ischemic heart disease (IHD) being the primary cause of both morbidity and mortality. Despite optimal pharmacological therapy, older patients with IHD exhibit an increased susceptibility to recurrent ischemic events, significantly impacting their prognosis. Inflammation is intricately linked with the aging process and plays a pivotal role in the evolution of atherosclerosis. Emerging anti-inflammatory therapies have shown promise in reducing ischemic events among high-risk populations. This review aims to explore the potential of targeted anti-inflammatory interventions in improving clinical outcomes and the quality of life for older patients with IHD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- INCLIVA-Instituto de Investigación Sanitaria, Biomedical Research Institute, 46010 Valencia, Spain.
- Cardiology Department, Hospital Clinic Barcelona, 08036 Barcelona, Spain.
- Cardiology Department, Clinic University Hospital of Valencia, 46026 Valencia, Spain.
ORCID-Profile: Andrea Arroyo-Álvarez, Daznia Bompart Berroteran, Francisca Esteve Claramunt, Pedro Cepas-Guillén, Sergio Garcia-Blas, Clara Bonanad
Zitieren
APA
Maidana, D., Arroyo-Álvarez, A., Arenas-Loriente, A., Barreres-Martín, G., Muñoz-Alfonso, C., Bompart Berroteran, D., Esteve Claramunt, F., Blanco Del Burgo, R., Cepas-Guillén, P., Garcia-Blas, S., & Bonanad, C. (2024). Inflammation as a New Therapeutic Target among Older Patients with Ischemic Heart Disease. Journal of Clinical Medicine, 13(2), 363. https://doi.org/10.3390/jcm13020363
Vancouver
Maidana D, Arroyo-Álvarez A, Arenas-Loriente A, Barreres-Martín G, Muñoz-Alfonso C, Bompart Berroteran D, et al. Inflammation as a New Therapeutic Target among Older Patients with Ischemic Heart Disease. Journal of Clinical Medicine. 2024;13(2):363. doi:10.3390/jcm13020363
BibTeX
@article{Maidana2024,
author = {Maidana, Daniela and Arroyo-Álvarez, Andrea and Arenas-Loriente, Andrea and Barreres-Martín, Guillermo and Muñoz-Alfonso, Carles and Bompart Berroteran, Daznia and Esteve Claramunt, Francisca and Blanco Del Burgo, Regina and Cepas-Guillén, Pedro and Garcia-Blas, Sergio and Bonanad, Clara},
title = {Inflammation as a New Therapeutic Target among Older Patients with Ischemic Heart Disease},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {2},
pages = {363},
doi = {10.3390/jcm13020363}
}
EUVIMED